We are live on ! Find out more
NDSI

Newman Dignan & Sheerar Inc Portfolio holdings

AUM $523M
1-Year Est. Return 26.16%
This Fund
S&P 500
This Quarter Est. Return
+5.44%
1 Year Est. Return
+26.16%
3 Year Est. Return
+73.46%
5 Year Est. Return
+76.54%
10 Year Est. Return
+279.61%
AUM
$312M
AUM Growth
+$9.62M
Cap. Flow
-$2.44M
Cap. Flow %
-0.78%
Top 10 Hldgs %
32.27%
Holding
203
New
10
Increased
51
Reduced
90
Closed
8

Sector Composition

Rank Sector Weight
1 Technology 12.12%
2 Healthcare 8.02%
3 Financials 4.4%
4 Industrials 4.29%
5 Consumer Staples 3.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WYNN icon
176
Wynn Resorts
WYNN
$10.6B
$215K 0.07%
+1,922
New +$201K
CARR icon
177
Carrier Global
CARR
$52.8B
$215K 0.07%
+4,695
New +$210K
VGT icon
178
Vanguard Information Technology ETF
VGT
$149B
$215K 0.07%
+4,456
New +$197K
MTUM icon
179
iShares MSCI USA Momentum Factor ETF
MTUM
$25.5B
$207K 0.07%
1,489
-150
-9% -$21.2K
IVE icon
180
iShares S&P 500 Value ETF
IVE
$49.8B
$205K 0.07%
+1,353
New +$204K
FVD icon
181
First Trust Value Line Dividend Fund
FVD
$8.4B
$204K 0.07%
5,083
-137
-3% -$5.49K
TEL icon
182
TE Connectivity
TEL
$62.6B
$203K 0.07%
+1,550
New +$196K
ES icon
183
Eversource Energy
ES
$27.2B
$202K 0.06%
2,585
+1
+0% +$79
SCHP icon
184
Schwab US TIPS ETF
SCHP
$16.2B
$202K 0.06%
7,524
-3,624
-33% -$95.4K
MLCO icon
185
Melco Resorts & Entertainment
MLCO
$2.14B
$158K 0.05%
12,410
SNDL icon
186
Sundial Growers
SNDL
$320M
$55.1K 0.02%
34,420
AHT
187
Ashford Hospitality Trust
AHT
$21M
$52.4K 0.02%
1,633
OVID icon
188
Ovid Therapeutics
OVID
$491M
$40K 0.01%
15,522
CLSD
189
DELISTED
Clearside Biomedical
CLSD
$28.1K 0.01%
1,802
ONCY
190
Oncolytics Biotech
ONCY
$95.8M
$22.7K 0.01%
18,915
TCRR
191
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$18.8K 0.01%
12,522
MIR.WS
192
DELISTED
Mirion Technologies, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
MIR.WS
$16.1K 0.01%
10,023
APTO
193
DELISTED
Aptose Biosciences, Inc.
APTO
$12.1K ﹤0.01%
42
MDNA
194
DELISTED
Medicenna Therapeutics Corp. Common Shares
MDNA
$8.13K ﹤0.01%
12,915
DSS icon
195
DSS Inc
DSS
$5.13M
$3.98K ﹤0.01%
997
+129
+15% +$542
FLOT icon
196
iShares Floating Rate Bond ETF
FLOT
$10.5B
-6,579
Closed -$331K
FTSL icon
197
First Trust Senior Loan Fund ETF
FTSL
$2.33B
-10,866
Closed -$485K
INFL icon
198
Horizon Kinetics Inflation Beneficiaries ETF
INFL
$1.53B
-6,450
Closed -$203K
MMM icon
199
3M
MMM
$94.3B
-2,258
Closed -$226K
NSC icon
200
Norfolk Southern
NSC
$75.1B
-850
Closed -$209K

Similar funds

Newman Dignan & Sheerar Inc's Q1 2023 Portfolio in Review

As of Q1 2023, Newman Dignan & Sheerar Inc held 203 positions worth $312M, up 3.2% from $302M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Newman Dignan & Sheerar Inc's Q1 2023 filing shows 10 new, 51 increased, 90 reduced and 8 closed positions. Its largest new stake was Salesforce: 3,900 shares worth $779K. The largest sale was State Street Real Estate Select Sector SPDR ETF, an estimated $2.91M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 10% a quarter earlier, followed by Healthcare and Financials.

  • Newman Dignan & Sheerar Inc's largest Q1 2023 buy was Salesforce: 3,900 shares worth $779K.
  • Newman Dignan & Sheerar Inc added most to First Trust Preferred Securities and Income ETF in Q1 2023, an estimated $1.39M increase.
  • Newman Dignan & Sheerar Inc's biggest Q1 2023 reduction was Schwab US Dividend Equity ETF, cutting an estimated $1.05M.
  • Newman Dignan & Sheerar Inc fully exited State Street Real Estate Select Sector SPDR ETF in Q1 2023, selling an estimated $2.91M.
  • Newman Dignan & Sheerar Inc's ten largest holdings make up 32% of its $312M portfolio in Q1 2023.
  • Newman Dignan & Sheerar Inc opened 10 new positions and closed 8 in Q1 2023.
  • Newman Dignan & Sheerar Inc's portfolio value rose 3.2% quarter-over-quarter to $312M.

Based on Newman Dignan & Sheerar Inc's 13F filing for Q1 2023, filed 28 Apr 2023.